Norway
Nordics Life Science Trend Analysis 2026
Norway’s life science sector comprises 538 companies across biotechnology, medtech, digital health, pharma, investors, and supporting services. The 2026 Norway Life Science Trend Analysis, produced in partnership with The Life Science Cluster, highlights an ecosystem built on strong biotech foundations, growing digital health activity, and a pipeline concentrated in oncology and anti-infectives. The ecosystem includes […]
04 Jun 2026
Read moreNorway Life Science Trend Analysis 2025
The 2025 Norway Life Sciences Trend Analysis offers a comprehensive overview of one of Scandinavia’s most promising innovation hubs. With 531 active life science companies — including 179 biotech firms and 90 digital health players — Norway continues to strengthen its role in the Nordic life science landscape. This year’s report highlights a notable concentration […]
19 May 2025
Read moreNorway Life Science Trend Analysis 2024
In 2023, the Norwegian life science industry continues to show dynamism and innovation. With biotechnology companies comprising a substantial 48% of the life science sector, nearly half of these fall under the “Biotech – Other” category, which includes sectors such as AgBio, environmental, veterinary, and industrial biotechnology. Notably, digital health emerges as a key sector, […]
07 Jun 2024
Read moreNorway Life Science Trend Analysis 2023
The Norwegian life sciences industry performed well in 2022 compared to the years before 2021 (2018 – 2020), raising USD 38 million in private equity investments according to Biotechgate data. However, it could not compete with the record level of venture financing in 2021 (USD 65 million). Cytovation ASA secured the largest round in 2022. […]
31 Aug 2023
Read more